Series date: 
01/01/2025 - 7:00am +04 to 12/31/2025 - 8:00am +04

This activity is intended for internal CCAD Physicians

Activity Description:

This activity is based on the American College of Surgeons, Commission on Cancer standards. To meet the Commission on Cancer (CoC) standards for multidisciplinary cancer case conferences aka tumor boards cancer programs hold multidisciplinary cancer case conference(s) to evaluate patient management.

Target Audience: 

Family Practice, Hematology/Oncology, Nursing, Pathology, Pharmacology, Radiology, Surgery, Women's Health.

Learning Objectives:

  • Demonstrate proficiency in staying up to date on the latest advancements in gynecologic oncology research, treatment modalities, and evidence-based guidelines, including ovarian, cervical, endometrial, and vulvar cancers. This will be evident through the use of evidence based guidelines and care pathways for gynecologic cancers during tumor board meetings to develop personalized treatment plans for patients.
  • Exhibit effective communication and collaboration skills within the gynecologic oncology tumor board setting to foster efficient and coordinated patient care, including articulating viewpoints clearly, actively listening to others, and engaging in respectful dialogue.
  • Incorporate a patient-centered approach into the discussions had during the gynecologic tumor board. Participants will ensure patient preferences and values are considered when formulating treatment plans. Recognizing the importance of shared decision-making in the treatment planning process will enhance patient engagement and satisfaction.
  • Remain informed about emerging strategies and technologies in gynecologic cancer care, by continually evaluating and incorporating these advancements resulting in the highest quality and most effective care to patients.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). 

Cleveland Clinic Abu Dhabi is accredited by the ACCME to provide continuing medical education for physicians.

Each session of this activity is designated for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosure:

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Abu Dhabi requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they have no relationships which, in the context of their presentation, could be perceived as a potential conflict of interest:

Activity Director: Stephanie Ricci, MD

 

 

Series location: 
This activity is a physical meeting
Al Maryah Island
Abu Dhabi, AZ 112
United Arab Emirates

Sessions

Session Date
Gynecological Tumour Board Session 10/10/2025 - 12:00pm to 1:00pm +04
Gynecological Tumour Board Session 10/24/2025 - 12:00pm to 1:00pm +04
Gynecological Tumour Board Session 11/07/2025 - 12:00pm to 1:00pm +04
Gynecological Tumour Board Session 11/21/2025 - 12:00pm to 1:00pm +04
Gynecological Tumour Board Session 12/05/2025 - 12:00pm to 1:00pm +04
Gynecological Tumour Board Session 12/19/2025 - 12:00pm to 1:00pm +04

Pages